Valeo Pharma (TSE:VPH) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Valeo Pharma Inc., a Canadian pharmaceutical firm, is delisting its Class A shares from the OTCQB Venture Market due to low trading volume and high costs, focusing instead on the TSX and FSE markets. This strategic move, aimed to consolidate trading platforms, was announced by CEO Al Moghaddam, highlighting the TSX’s senior status and advanced trading system.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.